Materials and Methods for Treatment of Pain Related Disorders
Application
US20260078414A1
Kind: A1
Mar 19, 2026
Assignee
Vertex Pharmaceuticals Incorporated
Inventors
Ante Sven Lundberg, Samarth Kulkarni, Lawrence Klein, Hari Kumar Padmanabhan
Abstract
The present application provides materials and methods for treating a patient with one or more conditions associated with SCN9A whether ex vivo or in vivo. In addition, the present application provides materials and methods for editing and/or modulating the expression of SCN9A gene in a cell by genome editing.
CPC Classifications
C12N 15/907
A61K 35/30
C07K 14/705
C12N 9/22
C12N 15/11
C12N 15/1138
C12N 2310/20
C12N 2800/80
Filing Date
2025-09-16
Application No.
19330502